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Successful establishment of Yersinia infections requires the type III machinery, a protein transporter that
injects virulence factors (Yops) into macrophages. It is reported here that the Yersinia type III pathway
responds to environmental signals by transporting proteins to distinct locations. Yersinia enterocolitica cells
sense an increase in extracellular amino acids (glutamate, glutamine, aspartate, and asparagine) that results
in the activation of the type III pathway. Another signal, provided by serum proteins such as albumin, triggers
the secretion of YopD into the extracellular medium. The third signal, a decrease in calcium concentration,
appears to be provided by host cells and causes Y. enterocolitica to transport YopE and presumably other
virulence factors across the eukaryotic plasma membrane. Mutations in several genes encoding regulatory
molecules (lcrG, lcrH, tyeA, yopD, yopN, yscM1, and yscM2) bypass the signal requirement of the type III
pathway. Together these results suggest that yersiniae may have evolved distinct secretion reactions in
response to environmental signals.
Type III secretion systems represent a common pathogenic
tool of many gram-negative bacteria (20). Upon bacterial con-
tact with host cells, type III machines deliver protein toxins
across the eukaryotic plasma membrane. Once inside the cell,
these proteins manipulate host signal transduction pathways,
resulting in rearrangement of the cytoskeleton and in induc-
tion of an apoptotic program (45, 56). By injecting distinct sets
of toxins into the host, each pathogen appears to customize the
versatile type III device to suit their unique pathogenic strategy
(20). Recent work suggests a temporal and/or spatial regula-
tion of the type III secretion machinery during experimental
infections caused by Salmonella, enteropathogenic Escherichia
coli (EPEC), and Yersinia species. Salmonella species inject
two effector proteins, SopE and SptP, which display opposing
functions in the host cell (16). SopE, a GTP exchange factor
for CDC42 and Rac1, first induces membrane ruffling and
facilitates bacterial entry into the host cell (21). Injection of
SptP, a GTPase activating factor of CDC42 and Rac1, is
thought to restore the cytoskeletal rearrangements once the
bacterium is inside the host cell (19). Simultaneous microin-
jection of both effector proteins prevents cytoskeletal rear-
rangements, suggesting that a temporal regulation of the type
III machine is required to allow the two virulence factors to
function independently of each other in the host cell cytoplasm
(19).
Pathogenic Yersinia species, i.e., Yersinia pestis, Yersinia
pseudotuberculosis, and Yersinia enterocolitica, enter their hosts
via the intestines or by flea-borne contamination of skin lesions
(11). Once host barriers are breached, Yersinia colonizes lym-
phoid tissues or multiplies in blood to cause septicemic infec-
tions (6). The astonishing pathogenic potential of Yersinia is
executed by a type III secretion machinery that transports 14
Yops (Yersinia outer proteins) (11). When bacteria establish
contact with macrophages, the type III machinery injects some
of these virulence factors (YopEHMOPT, effector Yops) into
the cytosol of target cells (44), thereby abolishing the phago-
cytic process and inducing apoptosis of macrophages (35–37).
In addition to injecting toxins into host cells, the type III
machine can deliver substrate proteins to other locations. One
example of spatial separation of type III transport is EspA of
EPEC. EspA is secreted by the type III machinery and assem-
bled into bacterial surface appendages (27). The formation of
EspA filaments is required for the delivery of EspB and Tir
into host cells, indicating that the type III machinery must
distinguish secretion substrates to allow for differential deliv-
ery during infection (26, 27). Yersinia species also deliver type
III secretion substrates to distinct locations. During infection
of tissue culture cells, yersiniae secrete YopB, YopD, and
YopR into the extracellular milieu (30), whereas effector Yops
(YopE, YopH, YopM, YopO, YopP, and YopT) are injected
into the cytosol of host cells (5, 45). Thus, as reported for
EPEC, yersiniae may also distinguish between different sets of
secretion substrates.
What are the environmental signals that activate secretion
via the Yersinia type III pathway? Early work established a
requirement for calcium to allow growth of pathogenic
yersiniae at 37°C on artificial medium (28). Later studies
showed that the chelation of calcium together with a temper-
ature shift to 37°C triggers the type III secretion of Yops (18,
33, 49). The calcium concentration of extracellular host fluids
(1.2 mM) is well above the threshold required for induction of
type III machines (12). Nevertheless, Yersinia type III ma-
chines are activated during infection, a phenomenon that is
referred to as the calcium paradox (12). It has been proposed
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that phagocytosis exposes bacteria to the low-calcium environ-
ment of the endocytic pathway, activating type III gene expres-
sion and providing a mechanism for Yersinia target cell selec-
tion (40). This possibility now seems somewhat remote, as the
type III injection of effector Yops is believed to be catalyzed by
extracellular Yersinia (45).
The observation that bacterial contact with host cells causes
an increase in virulence gene expression provides a clue to
understanding calcium signaling during type III secretion (38).
It is thought that receptors on the bacterial surface may inter-
act with specific ligands on the surface of host cells (11). This
interaction may activate the type III machinery and remove the
YopN-mediated block of the type III pathway (11, 17). How-
ever, Yersinia surface receptors that are necessary for type III
injection or the corresponding ligand on the surface of eukary-
otic cells have thus far not been identified. It is reported here
that host cells may generate the calcium signal that leads to
activation of the type III pathway. A mechanism is proposed
whereby yersiniae measure the intracellular calcium of target
cells. Further, activation of the Yersinia type III pathway is
shown to require two other signals, i.e., serum amino acids
(glutamate, glutamine, aspartate, or asparagine) and proteins
such as albumin. Yersiniae respond to temperature shift and
glutamate with the expression and assembly of the type III
machinery. Albumin triggers Yersinia type III secretion of
YopD into the extracellular milieu. Host cell contact trans-
forms the type III machinery into an injection device that
transports YopE across the plasma membrane into the eukary-
otic cytosol. Mutations in Yersinia regulatory genes (lcrG, lcrH,
tyeA, yopD, yopN, yscM1, and yscM2) disrupt this type III se-
cretion program and bypass the requirement for specific sig-
nals.
MATERIALS AND METHODS
Bacterial strains and plasmids. Y. enterocolitica O:9 strain W22703 (13) and
isogenic variants with frameshift mutations in D(yopB) (30), D(yopD) (32),
D(yopN) (29), D(yopQ) (2), and D(yopR) (30) or deletions in D(lcrG) (15),
D(lcrV) (31), D(lcrH) (D. M. Anderson, K. Ramamurthi, C. Tam, and O. Schnee-
wind, submitted for publication), D(sycH) (7), D(tyeA) (9), and D(yscM1/yscM2)
(7) have been previously described. Plasmids pDA35 and pDA37 have also been
previously described (1).
Type III secretion in DMEM. Yersinia strains were grown overnight at 26°C
with shaking. Cultures were diluted 1:20 into 30 ml of fresh Luria broth and
incubated at 26°C for 2 h. Bacteria were collected by centrifugation and were
washed, and 2.5 3 108 CFU was added to 10 ml of Dulbecco’s modified Eagle
medium (DMEM) in 75-cm2 tissue culture flasks. Cultures were incubated for
3 h at 37°C and 5% CO2. Bacteria were scraped off the flasks, and the culture was
transferred to a 15-ml conical tube. Yersinia strains were sedimented by centrif-
ugation at 12,000 3 g. Five milliliters of the culture supernatant was removed and
precipitated with methanol-chloroform. The remaining supernatant was dis-
carded. The Yersinia sediment was suspended in 1 ml of phosphate-buffered
saline (PBS), and a 0.5-ml aliquot was precipitated with methanol-chloroform.
Proteins were collected at the interphase after centrifugation at 12,000 3 g. After
removal of the aqueous phase, proteins were washed with methanol and sedi-
mented by centrifugation at 12,000 3 g. The precipitate was dried, suspended in
sample buffer, and analyzed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and immunoblotting. Immunoreactive species were
quantified as chemiluminescent signals on X-ray film using laser densitometry
scanning.
Digitonin fractionation. Overnight cultures of Yersinia strains were diluted
1:20 into 30 ml of fresh Luria broth and grown for 2 h at 26°C with shaking.
Bacteria were sedimented at 8,000 3 g for 10 min and suspended in PBS. HeLa
cells were grown to 80% confluency in 75-cm2 tissue culture flasks with DMEM
and 10% fetal bovine serum (FBS). Prior to infection, cells were washed twice
with PBS, covered with 10 ml of DMEM, and warmed to 37°C for 30 min.
Aliquots of HeLa cells were counted, and each flask was infected with yersiniae
at a multiplicity of infection of 10 and incubated for 3 h at 37°C with 5% CO2.
Culture media were removed and centrifuged at 32,000 3 g for 15 min to
separate soluble proteins from nonadherent bacteria in the sediment. HeLa cells
as well as adherent bacteria were scraped off the flasks into 10 ml of 1% digitonin
in PBS and placed on a rotary shaker for 20 min. Samples were centrifuged at
32,500 3 g for 15 min. A 7-ml aliquot was withdrawn and precipitated with
methanol-chloroform, while the remaining supernatant was discarded. The sed-
iment was suspended in 10 ml of PBS, and a 7-ml aliquot was precipitated with
methanol-chloroform. Protein precipitates were solubilized in sample buffer,
separated on SDS-PAGE, and analyzed by immunoblotting with specific anti-
serum. Immunoreactive species were quantified as chemiluminescent signals on
X-ray film using laser densitometry scanning.
Preparation of environmental signals. Unless otherwise indicated, glutamate
was prepared as a stock of 68 mM monosodium glutamate (Fisher BP378) in
water, sterile filtered, and diluted 1:5,000 to yield a final concentration of 135 mM
in DMEM. Unless otherwise indicated, purified bovine albumin (Sigma A-7638)
was prepared as a stock of 1.5 mM albumin in PBS (10% wt/vol), sterile filtered,
and diluted 1:1,000 to yield a final concentration of 1.5 mM in DMEM. DMEM
without (GIBCO-BRL 21068-028) or with (GIBCO-BRL 11960-051) 1.8 mM
calcium was used in these experiments. Heat-inactivated FBS (Gemini Bioprod-
ucts) was stored in frozen aliquots, melted, and diluted to a final concentration
of 0.2% (vol/vol). For protease digestion, proteinase K (100 ml of a 100-mg/ml
solution in PBS [Roche]) was incubated with 10 ml of FBS for 6 days at 4°C.
Protease digestion was quenched by the addition of phenylmethylsulfonyl fluo-
ride to 0.1 mM. Ten milliliters of FBS was dialyzed once against 100 ml of PBS
for 12 h at 4°C using a membrane with a permeability barrier of 8 kDa (Spectrum
Laboratories 132650); the dialysate was collected and used at a 2% (vol/vol)
dilution in DMEM. After two additional dialysis steps, i.e., dialysis against 500 ml
of PBS each for 12 h at 4°C using the same membrane, dialyzed FBS was
recovered and tested for induction of type III secretion at a dilution of 0.2% in
DMEM. Cohn’s serum fractions were purchased from Sigma (Cohn I [fibrino-
gen], F-4753; Cohn II/III [g-globulin], G-5009; Cohn IV-1, G-8512; Cohn IV-4,
G-8637; Cohn V [albumin]; and A-8022). Cohn fractions were prepared as a 10%
stock (wt/vol) in PBS, sterile filtered, and diluted 1:1,000 to yield a final concen-
tration of 0.01% in DMEM.
RESULTS
Yersinia infection of HeLa cells in the presence and absence
of calcium. We wondered whether the specificity of effector
Yop injection is controlled by Yersinia recognition of a host
signal, presumably a change in calcium concentration. Activa-
tion of the Yersinia type III machinery was measured by infect-
ing and fractionating tissue cultures by the digitonin technique
(29). Briefly, HeLa cell cultures were infected with Y. entero-
colitica W22703 for 3 h. The growth medium was removed and
centrifuged to separate nonadherent bacteria from the extra-
cellular medium. HeLa cells and yersiniae adherent to the
culture flasks were treated with digitonin, a detergent that
disrupts the eukaryotic plasma membrane but not the bacterial
envelope (29). Samples were centrifuged to separate the HeLa
cell cytosol from the bacterial sediment. During HeLa cell
infection in DMEM tissue culture medium with 1.8 mM cal-
cium, Y. enterocolitica W22703 secreted YopD into the extra-
cellular medium and injected YopE into the cytosol (Fig. 1A).
Small amounts of YopD were also observed in the supernatant
of digitonin-extracted HeLa cells. As a control for proper frac-
tionation, p130cas, a protein in the HeLa cell cytosol, was
solubilized by digitonin extraction of tissue culture cells. In
contrast, Yersinia Npt (neomycin phosphotransferase, encoded
by npt carried by pDA37) was not solubilized by digitonin
treatment and sedimented with the bacteria after centrifuga-
tion of tissue culture extracts. When HeLa cells were infected
in DMEM lacking calcium, Yersinia strains secreted both
YopD and YopE into the extracellular medium (Fig. 1A).
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These results suggest that the specific injection of YopE via the
Yersinia type III pathway requires extracellular calcium.
Can the cytosol of HeLa cells generate the calcium signal for
the injection of YopE? To address this possibility, HeLa cells
were lysed with 0.1% Triton X-100 in DMEM with 1.8 mM
calcium, an extraction that also disrupts the calcium gradient
across the plasma membrane. As a control, detergent treat-
ment solubilized p130cas, indicating that the plasma mem-
brane, and therefore the calcium gradient across the plasma
membrane, had been disrupted (Fig. 1B). Infection of the
HeLa cell lysate with yersiniae in the presence of 1.8 mM
calcium failed to activate YopE secretion. In contrast, secre-
tion of YopD still occurred, albeit at a greatly reduced rate. To
examine whether the removal of extracellular calcium can sub-
stitute for the calcium signal that is generated by intact HeLa
cells, tissue cultures were lysed with 0.1% Triton X-100 in
DMEM without calcium. Infection of lysate without calcium
resulted in Yersinia type III transport of YopD and YopE (Fig.
1B). Further, the removal of calcium ions from HeLa cell
extracts led to an increase in the concentration of YopD and
YopE, suggesting that yop gene expression may also be stim-
ulated under these conditions (see Table 1 and Table 2 for the
regulatory effects of low-calcium signaling). Together these
results suggest that intact HeLa cells may generate the calcium
signal that activates the transport of YopE. Results similar to
those described above were obtained when HeLa cells were
lysed by sonication, shearing, or digitonin treatment (data not
shown), suggesting that the method of HeLa cell lysis does not
affect the calcium signaling in this experiment.
Calcium concentration required for Yersinia type III secre-
tion. To determine the critical concentration of calcium re-
quired to induce type III secretion, Y. enterocolitica W22703
(pDA37) was grown in DMEM supplemented with 0.2% FBS
(final concentration) and various amounts of calcium chloride
(CaCl2) at 37°C for 3 h. Variations in the concentration of
calcium were achieved by mixing DMEM without calcium and
DMEM with calcium. The concentration of calcium was veri-
fied by measuring these ions directly with a calcium electrode.
Yersinia cultures were centrifuged, and the extracellular me-
dium was separated with the supernatant from the sedimented
bacteria in the pellet). Proteins in both fractions were precip-
itated with chloroform-methanol and analyzed by SDS-PAGE
and immunoblotting with specific antisera. In Fig. 2 the pro-
portion of secreted Yop (percent amount of the total) is plot-
ted against the extracellular calcium chloride concentration.
We observed a reduction in the amount of secreted YopE
when the extracellular calcium chloride concentration reached
FIG. 1. A calcium signal induces Yersinia type III targeting of
YopE but not type III secretion of YopD. (A) HeLa cells in DMEM
with (1Ca21) or without (2Ca21) 1.8 mM calcium were infected with
Y. enterocolitica W22703. The culture medium (Med) was decanted
and centrifuged, separating the extracellular medium (S, supernatant)
from the bacterial sediment (P, pellet). HeLa cells were extracted with
digitonin (Dig). After centrifugation, proteins in the cytosol of HeLa
cells (S, supernatant) were separated from the bacterial sediment (P,
pellet). Samples were analyzed by immunoblotting. p130cas is located
in the cytosol of HeLa cells, whereas Npt is located in the bacterial
cytoplasm. (B) HeLa cells in DMEM with or without 1.8 mM calcium
were lysed with Triton X-100 (TX-100). Cell lysates were infected with
Yersinia and centrifuged to separate the extracellular medium (S) from
the bacterial sediment (P).
TABLE 1. Expression of YopE by Y. enterocolitica
W22703(pDA35) grown in DMEM at 37°C
Signal(s) added
Amt. of YopE in culture with (1) or
without (2) Ca21a
2Ca21b 2Ca21c 1Ca21b 1Ca21c
79 (20) 55 (7) 74 (26) 65 (18)
Glutamate 140 (105) 99 (12) 98 (54) 78 (16)
Albumin 62 (28) 80 (32) 64 (8) 75 (15)
Glutamate and albumin 150 (14) 237 (72) 94 (17) 123 (3)
FBS 150 (14) 267 (151) 100d 100d
a Numbers indicate the percent amount of YopE present in Y. enterocolitica
cultures. Numbers in parentheses represent the standard deviation of the mea-
surement.
b Data were generated by trichloroacetic acid precipitating cultures, separating
proteins on SDS-PAGE, and immunoblotting with YopE-specific antiserum.
Numbers represent averages of three independent experiments. Data were mul-
tiplied with a correction factor for the bacterial density, which was determined by
measuring the optical density at 660 nm of Yersinia cultures.
c Data were generated as described above and multiplied with a correction
factor for an immunoreactive signal obtained with chloramphenicol acetyltrans-
ferase-specific antibodies. cat is carried by pDA35 and is not part of the yop
regulon.
d The average amount of YopE in Y. enterocolitica W22703 cultures grown in
DMEM supplemented with FBS was arbitrarily assigned a value of 100%.
TABLE 2. Expression of YopD by Y. enterocolitica
W22703(pDA35) grown in DMEM at 37°C
Signal(s) added
Amt. of YopD in culture with (1) or
without (2) Ca21a
2Ca21b 2Ca21c 1Ca21b 1Ca21c
77 (4) 55 (12) 73 (4) 68 (32)
Glutamate 174 (127) 124 (23) 118 (59) 99 (27)
Albumin 65 (31) 85 (39) 54 (14) 63 (22)
Glutamate and albumin 181 (34) 289 (111) 97 (16) 128 (5)
FBS 113 (29) 241 (122) 100d 100d
a Numbers indicate the percent amount of YopD present in Y. enterocolitica
cultures. Numbers in parentheses represent the standard deviation of the mea-
surement.
b Data were generated by trichloroacetic acid precipitating cultures, separating
proteins on SDS-PAGE, and immunoblotting with YopD-specific antiserum.
Numbers represent averages of three independent experiments. Data were mul-
tiplied with a correction factor for the bacterial density, which was determined by
measuring the optical density at 660 nm of Yersinia cultures.
c Data were generated as described above and multiplied with a correction
factor for an immunoreactive signal obtained with chloramphenicol acetyltrans-
ferase-specific antibodies.
d The average amount of YopD in Y. enterocolitica W22703 cultures grown in
DMEM supplemented with FBS was arbitrarily assigned a value of 100%.
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100 mM. At 200 mM calcium chloride, all Y. enterocolitica
secretion of YopE was blocked. These observations corrobo-
rate the previous finding that Y. pestis activates the expression
of a yopK (yopQ)-lacZ transcriptional fusion when the calcium
chloride concentration drops below 200 mM (40). It should be
noted, however, that these studies measured reporter protein
expression but not type III secretion. These findings are con-
sistent with the observed expression of YopD and YopE shown
in Fig. 1B. It therefore appears that the low-calcium signal may
regulate yop gene expression as well as the activity of the type
III machinery. In contrast to the block in secretion of YopE, a
low-level secretion of YopD (about 10%) was observed even at
a calcium chloride concentration of 1,800 mM. Nevertheless,
reducing the calcium chloride concentration below 100 mM
caused Y. enterocolitica to increase the secretion of YopD (40
to 50%). During Yersinia infection of HeLa tissue cultures or
HeLa lysates, comparatively more YopD was secreted in the
presence of 1.2 mM calcium. The reason for this discrepancy is
unknown. In summary, the critical concentration of calcium
required to activate Yersinia type III transport of YopE is #80
mM (Fig. 2), a level that is well above the intracellular calcium
concentration of HeLa cells (100 nM) (3). We propose that
Yersinia strains may have evolved a mechanism to measure
calcium ions across the eukaryotic plasma membrane. Presum-
ably, this mechanism requires contact between Yersinia cells
and eukaryotic cells. Hoiczyk and Blobel reported that the
YscF-containing needle complexes of Y. enterocolitica are re-
sponsible for the formation of a type III targeting conduit
between bacteria and eukaryotic cells (23). These results may
have identified the device with which yersiniae sense calcium.
As Yersinia needle complexes are assembled prior to host cell
contact (23), the insertion of this structure into eukaryotic cells
may allow bacteria to measure the change in environmental
calcium concentration and thereby activate the type III path-
way.
Glutamate activates the Yersinia type III machinery. When
bacteria are grown in brain heart infusion or other complex
media and incubated at 37°C in the absence of calcium ions,
Yersinia type III secretion is induced (34). Growth of Y. en-
terocolitica in DMEM tissue culture medium at 37°C without
HeLa cells failed to activate the type III transport of YopD
and YopE, even in the absence of calcium ions (Fig. 3). This
was a surprising result, as the removal of calcium and the
incubation at 37°C were hitherto thought to be sufficient as
signals for the activation of the Yersinia type III pathway (14).
Secreted extracellular Yops are known to aggregate and to
precipitate on the surface of glass and plastic containers (34).
We wondered whether the lack of YopD and YopE secretion
observed in Fig. 3 is caused by the aggregation of Yops. Yer-
sinia cultures were grown in the presence of 0.1% Triton
X-100, a condition that is known to prevent the aggregation of
some Yops (1). However, growth of Yersinia in the presence of
0.1% Triton X-100 did not result in the appearance of soluble,
extracellular YopD or YopE. It seems that YopD and YopE
sediment with the bacteria when yersiniae are grown in
DMEM without FBS, because the type III secretion machinery
is not activated under these conditions.
Supplementation of DMEM with 0.2% FBS restored the
ability of Y. enterocolitica W22703 to secrete YopD in the
presence of calcium as well as YopD and YopE in the absence
of calcium (Fig. 3). These data suggest that Yersinia requires
serum signals to activate the type III pathway. Similar obser-
vations have been made for Salmonella and Shigella species,
suggesting that many gram-negative pathogens activate the
type III pathway in response to serum components (32, 55).
FBS was dialyzed to remove small molecules (#8 kDa). This
treatment removed the signal(s) required to induce Yersinia
type III secretion (Fig. 4). However, when equal parts of dia-
lyzed FBS and dialysate were mixed, the inducing signal(s)
could be reconstituted, as yersiniae were once again activated
for YopD and YopE secretion in the absence of calcium as
well as for YopD secretion in the presence of calcium (Fig. 4).
DMEM contains most of the small molecules (amino acids,
carbohydrates, ions, and salts) that are present in serum or
extracellular fluids. However, 6 amino acids are absent (glu-
tamine, glutamate, asparagine, aspartate, proline, and ala-
nine). The addition of glutamate, glutamine, aspartate, or as-
paragine to DMEM without calcium each activated Yersinia
type III secretion of YopD and YopE, whereas addition of
proline or alanine had no effect (Fig. 5A) (data not shown).
The critical concentration of amino acids required for activa-
tion of type III secretion is $70 mM (data not shown), a level
FIG. 2. Yersinia type III secretion of YopE and YopD is regulated
by extracellular calcium ions. Y. enterocolitica W22703(pDA37) was
grown in DMEM supplemented with 0.2% fetal bovine serum for 3 h.
Cultures were centrifuged, and the extracellular medium was sepa-
rated with the supernatant from the bacterial sediment. Protein in both
fractions was precipitated with methanol-chloroform, separated on
SDS-PAGE, and analyzed by immunoblotting with antiserum raised
against purified YopD or YopE.
FIG. 3. FBS activates the Yersinia type III pathway. Y. enterocolitica
W22703(pDA37) was grown in DMEM without FBS and with or
without calcium. The medium was supplemented with 0.2% FBS or
0.1% Triton X-100 (TX-100) as indicated. Type III secretion was
measured as described in the legend to Fig. 2. S, supernatant; P, pellet.
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that is below that of the amino acid concentration in serum
(300 mM) (48). Glutamate proved to be the most potent in-
ducer of the type III pathway and was used at a final concen-
tration of 135 mM for all subsequent experiments. Glutamate
and aspartate chelate calcium ions; the concentration at which
these amino acids are added to DMEM does not lead to
significant changes in the concentration of extracellular cal-
cium ions that could explain the observed activation of the type
III pathway (data not shown).
Albumin activates the type III secretion of YopD. Digestion
of FBS with proteinase K abolished the signal(s) that activates
type III secretion (Fig. 3). Addition of glutamate alone to
DMEM with calcium also did not activate Yersinia type III
secretion of YopD (Fig. 5). It therefore appears that gluta-
mate, as well as glutamine, aspartate, and asparagine, induces
the low-calcium transport of Yops; however, additional serum
components seem required to activate type III secretion of
YopD in the presence of calcium. When combined with glu-
tamate, dialyzed FBS stimulated the secretion of YopD in
DMEM with calcium (data not shown). To test whether serum
proteins (.8 kDa) activate type III secretion, we analyzed
various Cohn fractions (I through V; Sigma Pharmaceuticals),
generated by ethanol precipitation of bovine serum (10). When
added to DMEM with glutamate and calcium, each of the five
Cohn fractions (100 mg of protein/ml) activated type III secre-
tion of YopD (Fig. 5B). This result suggests that many different
serum proteins are capable of activating the type III secretion
pathway. To test this prediction, albumin, a serum protein that
is abundantly present in the blood of many mammals (42), was
examined (42). When added to DMEM with glutamate and
calcium, bovine albumin induced Yersinia type III secretion of
YopD (Fig. 5A). The concentration of albumin required for
induction of type III secretion ($0.3 mM; data not shown) was
below that present in human serum (600 mM) (42). Extracel-
lular YopD and YopE, secreted by yersiniae growing in the
presence of albumin, migrated more slowly on SDS-PAGE
than intrabacterial YopD and YopE. This was explained as an
overloading of the SDS-PAGE with albumin, a condition that
may artifactually alter the mobility of faster-migrating proteins
such as YopD and YopE. The molecular properties of serum
proteins that activate type III secretion are not known. It is
conceivable that peptide sequences, folded structure, or post-
translational modifications function as a signal.
The addition of glutamine, albumin, FBS, or calcium to
DMEM appears to affect the expression of yopE or yopD. If so,
the regulation of YopD and YopE secretion that is reported
here could, in fact, be caused by a regulatory effect of gene
expression. To address this possibility, Y. enterocolitica W22703
(pDA35) cultures were grown in DMEM with or without var-
ious inducers. The cell density was measured, and proteins in
the culture were precipitated with methanol-chloroform. After
separation of proteins on SDS-PAGE and immunoblotting,
YopE and YopD were quantified by chemiluminescent mea-
surement of immunoreactive signals and their expression levels
were calculated (Table 1 and Table 2). The addition of gluta-
mate and albumin and the addition of FBS as well as the
omission of calcium resulted in a weak stimulation of yopD and
yopE expression. The addition of glutamine and albumin alone
had little or no effect. These data suggest that glutamine,
albumin, and calcium cause weak regulatory effects on yopD
and yopE expression in addition to regulating the secretion of
YopD and YopE polypeptides by the Yersinia type III machin-
ery.
Mutations in yopD, lcrH, or yscM1/M2 bypass the glutamate
signal. The type III pathway is modulated by glutamate, albu-
min, and calcium signals. Presumably, each of these signals
modulates the activity of the secretion machinery by a distinct
mechanism, requiring the function of regulatory genes. If so,
mutations in regulatory genes should abolish the signal re-
quirement of the type III machinery. This prediction was first
tested for glutamate. Previous work identified genes that reg-
ulate the Yersinia type III pathway (4, 8, 14, 25, 41, 43, 47, 54).
FIG. 4. Dialysis of FBS abolishes the Yersinia type III inducing
activity. Y. enterocolitica W22703(pDA37) was grown in DMEM with
or without calcium supplemented with 0.2% dialyzed FBS, the dialy-
sate of this reaction mixture, or a mixture of both. Type III secretion
was measured as described in the legend to Fig. 2. S, supernatant; P,
pellet.
FIG. 5. Glutamate and albumin activate the Yersinia type III path-
way. (A) Y. enterocolitica W22703(pDA37) was grown in DMEM with
or without calcium supplemented with glutamate (Glu) and albumin
(Alb), alone or in combination, as indicated. Type III secretion was
measured as described in the legend to Fig. 2. (B) Y. enterocolitica
W22703(pDA37) was grown in DMEM with calcium supplemented
with glutamate and a Cohn serum fraction (I, II, III, IV-1, IV-4, or V),
as indicated. S, supernatant; P, pellet.
4974 LEE ET AL. J. BACTERIOL.
We wondered whether mutations that result in a loss-of-func-
tion phenotype for yopBDNQR, lcrGVH, sycH, tyeA, or yscM1/
yscM2 abolish the glutamate requirement of the Yersinia type
III pathway. Yersiniae were grown in DMEM without calcium,
glutamate, albumin, or FBS. Mutations in yopD, lcrH (sycD), or
yscM1/yscM2 allowed yersiniae to secrete YopE, whereas all
other mutations had no effect (Fig. 6). lcrH and yscM1/yscM2
mutants failed to secrete YopD and YopE in DMEM with
calcium, suggesting that these mutations bypass the require-
ment for glutamate but not for albumin or calcium (Fig. 6; data
for albumin not shown). Furthermore, yopD mutants do not
secrete YopB in DMEM with calcium (data not shown).
YopD, LcrH, and YscM1/YscM2 (LcrQ) seem to control Yop
secretion at the same step and appear to function as a switch
that allows secretion of type III substrates in response to glu-
tamate. The lcrH mutant strain contained reduced amounts of
YopD; this can be explained by the lacking chaperone function
of LcrH (SycD), a small cytoplasmic protein that binds to
YopD (50). The sycH mutant Yersinia strain synthesized very
little, if any, YopD and YopE (Fig. 6). SycH acts as a secretion
chaperone and functional inhibitor for YscM1/YscM2, the
negative regulators of the Y. enterocolitica type III pathway (7,
47). Thus, the sycH mutant phenotype can be explained as
YscM1/YscM2-mediated inhibition of yopE expression (7).
Mutations in yopN, lcrG, and tyeA bypass the calcium signal.
When bacteria are grown in rich medium, mutations in yopN
(lcrE) abrogate the calcium signal requirement of Yersinia and
activate the type III machinery in the presence of 1.8 mM
calcium (54). YopN has been proposed to act as both a calcium
sensor on the surface of Yersinia and as a stop valve that
occludes the type III machinery (11, 17). Type III export of
YopN itself is regulated in a complex manner. The secretion
chaperones YscB and SycN bind to the N-terminal portion of
YopN (14). TyeA, a small polypeptide that interacts with the
C-terminal end of YopN (24), seems to act as a negative
regulator of YopN secretion (9 and L. W. Cheng, O. Kay, and
O. Schneewind, submitted for publication). Yersinia carrying
deletion mutations in sycN, tyeA, and yscB display a calcium-
blind phenotype similar to that of yopN mutants (14, 25). We
asked whether mutations in yopBDNQR, lcrGVH, sycH, tyeA,
or yscM1/yscM2 abolish the calcium regulation of the Yersinia
type III pathway. Yersinia strains were grown in DMEM with
calcium and 0.2% FBS. Mutations in yopN, lcrG, or tyeA al-
lowed yersiniae to secrete YopE in the presence of calcium,
whereas all other mutations had no effect (Fig. 7). These data
suggest that DMEM supplemented with 0.2% FBS resembles
other rich laboratory media and allows induction of type III
secretion upon removal of calcium ions. Mutations in lcrG are
known to cause a calcium-blind phenotype in mutant yersiniae
which is corroborated by the data shown in Fig. 7 (15, 46).
yopN mutant yersiniae failed to secrete Yops when grown in
DMEM without glutamate and calcium (Fig. 8A). Apparently,
these mutants are still capable of regulating type III secretion
and may require glutamate for induction. Although glutamate
allowed secretion in the absence of calcium, yopN mutants
failed to activate the type III pathway in DMEM with gluta-
mate and calcium (Fig. 8A). Only the addition of glutamate
and albumin triggered yopN mutants to secrete Yops in the
presence of calcium (Fig. 8A). Several conclusions can be
drawn from these experiments. (i) Full induction of the type III
pathway requires all three signals: glutamate, albumin, and
calcium. (ii) The three signals activate Yersinia in a sequential
manner: glutamate and then albumin and calcium. (iii) When
yersiniae are grown in DMEM with glutamate, calcium signal-
ing of yopN mutants occurs in a manner similar to that of
wild-type strains. This result suggests that YopN cannot func-
tion as a calcium sensor for the type III pathway. (iv) As
suggested previously, mutations in yopN, tyeA, sycN, and yscB
bypass the calcium signal requirement of the Yersinia type III
pathway (17, 24), suggesting that these genes provide a stop
valve function for the type III machinery (12). (v) The stop
valve is not implemented unless yersiniae receive glutamate
and albumin signals.
Sequential activation of the type III machinery. The type III
pathway appears to be activated by a sequence of signals:
glutamate and then albumin and calcium. If so, albumin alone
should activate the type III pathway of D(yopDN) yersiniae, as
these mutants are predicted to bypass the Yersinia requirement
for glutamate and calcium. This was tested, and D(yopDN)
yersiniae secreted YopB and YopE in DMEM with albumin
and calcium (Fig. 8B). The D(yopDN) mutant strain appears to
FIG. 6. Knockout mutations in yopD, lcrH, and yscM1/M2 bypass
the glutamate requirement for Yersinia type III secretion. Y. enteroco-
litica strains were grown in DMEM without FBS and without gluta-
mate. Type III secretion was measured as described in the legend to
Fig. 2. S, supernatant; P, pellet.
FIG. 7. Knockout mutations in yopN, lcrG, and tyeA bypass the
calcium requirement for Yersinia type III secretion. Y. enterocolitica
strains were grown in DMEM with FBS. Type III secretion was mea-
sured as described in the legend to Fig. 2. S, supernatant; P, pellet.
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be capable of sensing calcium, as YopB and YopE secretion in
DMEM without albumin occurred only in the absence but not
in the presence of calcium (Fig. 8B). Further, the D(yopDN)
mutant secretes YopE in DMEM alone (Fig. 8), similar to
yopD but unlike yopN mutant yersiniae (Fig. 6). These data
suggest that the regulatory function of yopD is epistatic over
that of yopN.
Type III secretion occurs prior to target cell contact. Glu-
tamate and albumin induce Yersinia type III secretion of
YopD. Bacterial sensing of these signals should occur imme-
diately upon host entry and before Yersinia encounters im-
mune cells. In contrast, type III injection of YopE requires
bacterial contact with the target cell and occurs later during
infection. We wondered whether the secretion machinery is
modified by target cell contact. In this scenario one would
expect nonadherent yersiniae to catalyze type III secretion of
YopB, YopD, and YopR. Target cell contact should transform
the machinery into an injection device that promotes type III
targeting but not secretion. To test this, HeLa cells were in-
fected with Y. enterocolitica W22703. After 1 h of infection,
more than 90% of the yersiniae adhered to tissue culture cells
(data not shown). The medium and nonadherent bacteria were
removed, and cells were washed and replenished with fresh
DMEM. After further incubation for 2 h, the cultures were
fractionated by the digitonin technique and analyzed by immu-
noblotting. Removal of nonadherent yersiniae seemed to re-
duce the secretion of YopB and YopD, whereas targeting of
YopE and YopH was not affected (Fig. 9). These results sup-
port the hypothesis that Y. enterocolitica transport of Yops may
occur in a sequential manner, beginning with type III secretion
of YopBD and followed by type III targeting of YopEH into
host cells.
DISCUSSION
A model is proposed whereby yersiniae enter the host and
respond to changes in temperature as well as to glutamate,
glutamine, asparagine, or aspartate with the assembly of the
type III machinery (Fig. 10). Albumin and other serum pro-
teins activate Yersinia to secrete YopB, YopD, and YopR into
the extracellular medium. Contact with immune cells trans-
forms the type III machinery into an injection device. The
molecular nature of calcium sensing is unknown. Electron mi-
croscopy experiments revealed the insertion of type III needles
into the plasma membrane of tissue culture cells (23). Such
needle insertion may not only serve Yop transport across
membranes but could also provide for the measurement of
calcium ions. Once stimulated by a low-calcium signal, Yersinia
transports effector proteins (YopE, YopH, YopM, YopO,
YopP, and YopT) across the plasma membrane. Several reg-
ulatory genes control this cascade of type III transport reac-
tions. lcrF (virF) encodes a transcription factor that activates
the expression of type III genes when the temperature is
shifted to 37°C (22, 51, 53). YopD, LcrH, and YscM1/YscM2
(LcrQ) prevent activation of the type III pathway in the ab-
sence of glutamate. Recent work suggests that YopD, LcrH,
and YscM1/YscM2 (LcrQ in Y. pestis and Y. pseudotuberculo-
sis) function in posttranscriptional regulation of yop gene ex-
pression (D. M. Anderson et al., submitted). As albumin is
required to activate type III secretion, other (hitherto uniden-
tified) genes may prevent transport of YopB, YopD, and
YopR. YopN, TyeA, SycN, YscB, and LcrG block the type III
injection step until Yersinia receives the calcium signal.
This model predicts that mutations in regulatory genes may
disrupt the Yersinia type III pathway at discrete steps. yopN,
lcrG, sycN, yscB, and tyeA mutations cause premature secretion
FIG. 8. A program of Yersinia type III secretion events is triggered
by specific host signals. Y. enterocolitica strains were grown in DMEM
without FBS and supplemented with glutamate (Glu) and/or albumin
(Alb) as indicated. Type III secretion was measured as described in the
legend to Fig. 2. (A) Knockout mutations in yopN; (B) knockout
mutations in yopD and yopN. S, supernatant; P, pellet.
FIG. 9. Type III secretion occurs prior to target cell contact. HeLa
cell cultures were infected with Y. enterocolitica W22703(pDA37). Af-
ter 1 h of infection, the medium of HeLa cells was removed to separate
nonadherent bacteria from Yersinia that had established target cell
contact. The samples were washed twice with PBS, and HeLa cells with
adherent yersiniae were covered with fresh DMEM and incubated for
2 h. Samples were fractionated and analyzed by immunoblotting. S,
supernatant; P, pellet; Med, culture medium; Dig, digitonin.
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of effector Yops into the extracellular medium (Los pheno-
type, for loss of type III targeting specificity) (15, 29, 45),
consistent with their presumed repressor function for the type
III pathway. yscM1/yscM2 mutant yersiniae transport massive
amounts of effector Yops into target cells, whereas sycH mu-
tants (YscM1/YscM2 chaperone) inject only small amounts of
YopEMOPT (7). These data suggest that the gene products of
yscM1/yscM2 and sycH alter the amplitude of Yop expression
without affecting the transport reactions of effector Yops. In
contrast, knockout mutations in yopD abolish type III targeting
without affecting secretion (Not phenotype, for no type III
targeting) (30, 45). The Not phenotype cannot be explained by
the repression of the type III pathway alone but must be
accounted for by the specific function of secreted proteins (45).
Thus, in order to advance through the type III program,
yersiniae not only receive glutamate, albumin, and calcium
signals but also catalyze specific transport reactions, such as the
secretion of YopD or the injection of YopN and YscM1/
YscM2.
What is the role of serum signals during Yersinia infection of
a mammalian host? It is presumed here that during host in-
fection, glutamate and albumin provide signals that lead to the
activation of the Yersinia type III pathway. Further, it is pre-
sumed that Yersinia receives the serum signals during the in-
fection of tissue culture cells. Experimental verification of
these assumptions are hindered by the fact that both animal
hosts of Yersinia infection as well as cultured human cells or
tissues release glutamate, glutamine, and proteins into the
extracellular medium (serum) (39, 42). Thus, simple omission
of glutamate and serum proteins from the media of tissue
culture cells cannot be achieved in an experimental protocol
that measures type III secretion and targeting during a pro-
longed time interval (3 h). It should be emphasized again that
many serum proteins in addition to albumin can activate the
secretion of YopBDR in the presence of calcium. It appears,
therefore, that yersiniae recognize a common property of se-
rum proteins and respond to this signal with type III secretion.
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